Epoetin alfa (Pooyesh Darou Pharmaceuticals)

阿法依伯汀（Pooyesh Darou）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin alfa (Pooyesh Darou Pharmaceuticals)
Drug Alias NameErythropoietin follow-on biologic (Pooyesh Darou Pharmaceuticals)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIran
Original Approved Date2009/01/01
Country/TerritoryIran
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPooyesh Darou
China Registration ClassN/A

Develop Information

Active CompaniesPooyesh Darou
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeB03XA01
Related LinksN/A